ATE496534T1 - Difluorierte piperidine zur behandlung von morbus alzheimer und verwandten leiden - Google Patents

Difluorierte piperidine zur behandlung von morbus alzheimer und verwandten leiden

Info

Publication number
ATE496534T1
ATE496534T1 AT07837578T AT07837578T ATE496534T1 AT E496534 T1 ATE496534 T1 AT E496534T1 AT 07837578 T AT07837578 T AT 07837578T AT 07837578 T AT07837578 T AT 07837578T AT E496534 T1 ATE496534 T1 AT E496534T1
Authority
AT
Austria
Prior art keywords
treatment
difluorinated
alzheimer
piperidine
disease
Prior art date
Application number
AT07837578T
Other languages
English (en)
Inventor
Matthew Stanton
Benito Munoz
David Sloman
Jed Hubbs
Christopher Hamblett
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE496534T1 publication Critical patent/ATE496534T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT07837578T 2006-09-07 2007-08-31 Difluorierte piperidine zur behandlung von morbus alzheimer und verwandten leiden ATE496534T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84272706P 2006-09-07 2006-09-07
PCT/US2007/019127 WO2008030391A2 (en) 2006-09-07 2007-08-31 Difluorinated piperidines for treatment of alzheimer's disease and related conditions

Publications (1)

Publication Number Publication Date
ATE496534T1 true ATE496534T1 (de) 2011-02-15

Family

ID=39157768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07837578T ATE496534T1 (de) 2006-09-07 2007-08-31 Difluorierte piperidine zur behandlung von morbus alzheimer und verwandten leiden

Country Status (8)

Country Link
US (1) US20100010041A1 (de)
EP (1) EP2063710B1 (de)
JP (1) JP2010502704A (de)
AT (1) ATE496534T1 (de)
AU (1) AU2007293395A1 (de)
CA (1) CA2662702A1 (de)
DE (1) DE602007012272D1 (de)
WO (1) WO2008030391A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2120584B1 (de) 2006-12-20 2012-06-20 Merck Sharp & Dohme Corp. Silylierte piperidinderivate
US9063797B2 (en) * 2011-09-19 2015-06-23 Varonis Systems, Inc. Method and apparatus for events handling in a multi-platform system
BR112014029233A8 (pt) * 2012-06-27 2019-01-29 Hoffmann La Roche método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
US10584127B2 (en) 2015-06-01 2020-03-10 Rugen Holdings (Cayman) Limited 3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists
WO2018098128A1 (en) 2016-11-22 2018-05-31 Rugen Holdings (Cayman) Limited Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0423356D0 (en) * 2004-10-21 2004-11-24 Merck Sharp & Dohme Therapeutic agents
CA2649996A1 (en) * 2006-04-26 2007-11-08 Merck Sharp & Dohme Limited Piperidines and related compounds for treatment of alzheimer's disease
EP2120584B1 (de) * 2006-12-20 2012-06-20 Merck Sharp & Dohme Corp. Silylierte piperidinderivate

Also Published As

Publication number Publication date
DE602007012272D1 (de) 2011-03-10
WO2008030391A3 (en) 2008-10-16
EP2063710B1 (de) 2011-01-26
CA2662702A1 (en) 2008-03-13
US20100010041A1 (en) 2010-01-14
WO2008030391A2 (en) 2008-03-13
JP2010502704A (ja) 2010-01-28
AU2007293395A1 (en) 2008-03-13
EP2063710A2 (de) 2009-06-03
EP2063710A4 (de) 2009-09-02

Similar Documents

Publication Publication Date Title
ATE455763T1 (de) Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit
WO2008099210A3 (en) Piperazine derivatives for treatment of ad and related conditions
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
ATE383853T1 (de) Arylessigsäuren und verwandte verbindungen zur behandlung von alzheimer-krankheit
ATE457989T1 (de) Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit
EA200802054A1 (ru) Ингибиторы фермента
EA200802213A1 (ru) Способы лечения заболеваний крови
BR0314611A (pt) Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
ATE529427T1 (de) Ä1h-indol-5-yl)-heteroaryloxyü-(1-aza-bicyclo- ä3.3.1ü-nonane als cholinergische liganden des n- achr zur behandlung psychotischer und neurodegenerativer leiden
DE602004023762D1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren
ATE460936T1 (de) Pyrazoloä1,5-aüpyrimidine derivate zur verwendung in der behandlung von morbus alzheimer und verwandten leiden
DE602007012272D1 (de) Difluorierte piperidine zur behandlung von morbus alzheimer und verwandten leiden
ES2378594T8 (es) Moduladores de piperidinilo y piperazinilo de la gamma-secretasa
NO20064951L (no) 1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse
ATE530525T1 (de) Piperidine und verwandte verbindungen zur behandlung von demenz
ATE512147T1 (de) Makrozyklische aminiopyridyl-beta-sekretase- hemmer zur behandlung von morbus alzheimer
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
DE602004026597D1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit
ATE452134T1 (de) Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
DE602005027677D1 (de) 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung
ATE437855T1 (de) (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties